N-(p-amylcinnamoyl)anthranilic acid

N-(p-amylcinnamoyl)anthranilic acid (ACA) is a modulator of various ion channels in the heart. N-(p-amylcinnamoyl)anthranilic acid is an effective reversible inhibitor of calcium-activated chloride channels and, to a lesser extent, cAMP-activated chloride channels, without affecting L-type calcium channels.[1] Calcium-activated chloride channels are believed to be involved in developing arrhythmia.[1][2]

Arrhythmia

Arrhythmia is a cardiac disease which is characterized by an irregular heartbeat. Some forms of arrhythmia are dangerous and life-threatening, while others are comparably minor. Heart cells (cardiac myocytes) contract due to an increase in the charge across the membrane (depolarization), which generates an action potential. Irregular contractions can cause arrhythmia to occur.[2][3]

Calcium-activated chloride channels

The calcium-activated chloride channel is present in cardiac myocytes of many species, such as rabbit[4][5] and pig,[1][6] but their presence in human cardiac myocytes is under debate. Some have provided evidence that these channels are present in human atrial cells,[7] while others have failed to find similar results.[8]

The calcium-activated chloride channel is an important component in the early phase of repolarization (bringing the charge across the membrane back to normal) of cardiac muscle cells,[9] contributing to the plateau formation during an action potential.[6] While the heart is at rest, the chloride channel current can be activated, causing an outward flow of chloride, inducing a depolarizing current. This current is generally large enough to generate an action potential, called a delayed after-depolarization. Delayed after-depolarizations can lead to arrhythmias.[2][10] Since the chloride channel is bound and activated by calcium, this tends to occur more often in cells that are already under calcium stress.[10] The calcium-activated chloride current is also doubled when stimulated by the sympathetic nervous system, likely due to an increase in calcium release, although the channel could potentially be under a direct control by the sympathetic nervous system.[2]

Treatment of Arrhythmia

Due to the ability of the calcium-activated chloride channel to generate arrhythmias, blockage of the channel may result in antiarrythmogenic action. Blocking the calcium current reduces delayed after-depolarization amplitudes enough to prevent generation of an action potential.[2] ACA has been shown to inhibit the calcium-activated chloride current, but this effect is reversible upon removal of the drug. ACA may also inhibit hyperpolarization of the cell, prolonging the action potential. ACA has potential as an antiarrhythmogenic treatment,[1][2] as well as a tool to further study chloride channels.[1]

References

  1. 1 2 3 4 5 Gwanyanya A, Macianskiene R, Bito V, Sipido KR, Vereecke J, Mubagwa K. "Inhibition of the calcium-activated chloride current in cardiac ventricular myocytes by N-(p-amylcinnamoyl)anthranilic acid (ACA)". Biochem Biophys Res Commun 2010;402:531–536.
  2. 1 2 3 4 5 6 Verkerk A, Veldkamp M, Bouman L, van Ginneken A. "Calcium-Activated Cl− Current Contributes to Delayed After depolarizations in Single Purkinje and Ventricular Myocytes". Circulation 2000;101:2639–2644.
  3. ↑ Guyton A, Hall J. Textbook of Medical Physiology, Tenth Ed. Philadelphia, PA:W.B. Saunders Company, 2000.
  4. ↑ Zygmunt AC, Gibbons WR. "Calcium-activated chloride current in rabbit ventricular myocytes". Circ Res 1991:68:424–437.
  5. ↑ Sipido KR, Callewaert G, Carmeliet E. "[Ca2+]i transients and [Ca2+]i-dependent chloride current in single Purkinje cells from rabbit heart". J Physiol 1993;468:641–667.
  6. 1 2 Li GR, Du XL, Siow YL, O K, Tse HF, Lau CP. "Calcium-activated transient outward chloride current and phase 1 repolarization of swine ventricular action potential". Cardiovasc Res 2003;58:89–98.
  7. ↑ Escande D, Coulombe A, Faivre JF, Deroubaix E, Coraboeuf E. "Two types of transient outward currents in adult human atrial cells". Am J Physiol 1987;252:H143–H148.
  8. ↑ Li GR, Feng J, Wang Z, Fermini B, Nattel S. "Comparative mechanisms of 4-aminopyridine-resistant Ito in human and rabbit atrial myocytes". Am J Physiol 1995;269:H463–H472.
  9. ↑ Kenyon JL, Gibbons WR. "4-Aminopyridine and the early outward current of sheep cardiac Purkinje fibers". J Gen Physiol 1979;73:139–157.
  10. 1 2 Zygmunt AC, Goodrow RJ, Weigel CM. "INaCa and ICl(Ca) contribute to isoproterenol-induced delayed after depolarizations in midmyocardial cells". Am J Physiol 1998;275:H1979–H1992.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.